» Articles » PMID: 29904630

Definition of NPSLE: Does the ACR Nomenclature Still Hold?

Overview
Specialty General Medicine
Date 2018 Jun 16
PMID 29904630
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) patients have frequently neuropsychiatric manifestations. From the first description of coma in 1875, a variety of manifestations has been described to occur in SLE. However, the lack of standardization reduced the comparability of published studies. In 1999, the American College of Rheumatology published guidelines to define neuropsychiatric nomenclature in SLE. This was the first step toward uniform diagnostic criteria. Several studies have been published since then applying the ACR criteria and frequencies of different manifestations can now be compared between cohorts. Although these criteria are diagnostic, therapeutic approach to different manifestations varies according to nature and severity of the manifestations. Herby, we will review the different definition for NPSLE published, and determine advantages and limitation.

Citing Articles

Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus.

Al-Ewaidat O, Naffaa M Medicines (Basel). 2024; 11(7).

PMID: 39189161 PMC: 11348055. DOI: 10.3390/medicines11070015.


Correlation between neuropsychiatric systemic lupus erythematosus and immunological markers: a real-world retrospective study.

Jiang Y, Yuan F, Xu X, Liu Y, Liang Y, Zhang Y Clin Rheumatol. 2024; 43(9):2833-2842.

PMID: 38997542 DOI: 10.1007/s10067-024-07056-6.


Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus.

Geng W, Zhang S, Cao J, Hong X, Duan Y, Jiang Y Front Immunol. 2024; 15:1323209.

PMID: 38585267 PMC: 10996363. DOI: 10.3389/fimmu.2024.1323209.


Autoimmune and neuropsychiatric phenotypes in a transgenic mouse model on C57BL/6 background.

Li Y, Zhang S, Tang C, Yang B, Atrooz F, Ren Z Front Immunol. 2024; 15:1370254.

PMID: 38524134 PMC: 10960363. DOI: 10.3389/fimmu.2024.1370254.


Neurological Manifestations of Connective Tissue Disorders.

Poshattiwar R, Acharya S, Shukla S, Kumar S Cureus. 2023; 15(10):e47108.

PMID: 38022020 PMC: 10646945. DOI: 10.7759/cureus.47108.


References
1.
Johnson R, Richardson E . The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore). 1968; 47(4):337-69. DOI: 10.1097/00005792-196807000-00002. View

2.
Unterman A, Nolte J, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G . Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2010; 41(1):1-11. DOI: 10.1016/j.semarthrit.2010.08.001. View

3.
Hanly J . Avoiding diagnostic pitfalls in neuropsychiatric lupus: the importance of attribution. Lupus. 2017; 26(5):497-503. DOI: 10.1177/0961203317690244. View

4.
How A, DENT P, Liao S, Denburg J . Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1985; 28(7):789-95. DOI: 10.1002/art.1780280710. View

5.
Postal M, Costallat L, Appenzeller S . Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management. CNS Drugs. 2011; 25(9):721-36. DOI: 10.2165/11591670-000000000-00000. View